N/A
Manufactured by Allergan, Inc.
16,640 FDA adverse event reports analyzed
Last updated: 2026-04-14
PREDNISOLONE ACETATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Allergan, Inc.. The most commonly reported adverse reactions for PREDNISOLONE ACETATE include TREATMENT FAILURE, DRUG INEFFECTIVE, EYE PAIN, OFF LABEL USE, VISION BLURRED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PREDNISOLONE ACETATE.
Out of 9,862 classified reports for PREDNISOLONE ACETATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16,640 FDA FAERS reports that mention PREDNISOLONE ACETATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include TREATMENT FAILURE, DRUG INEFFECTIVE, EYE PAIN, OFF LABEL USE, VISION BLURRED, EYE IRRITATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Allergan, Inc. in connection with PREDNISOLONE ACETATE. Always verify the specific product and NDC with your pharmacist.